[Federal Register Volume 85, Number 47 (Tuesday, March 10, 2020)]
[Notices]
[Page 13931]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-04829]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-582]


Bulk Manufacturer of Controlled Substances Application: S&B 
Pharma, Inc.; Correction

ACTION: Notice of application; correction.

-----------------------------------------------------------------------

SUMMARY: The Drug Enforcement Administration (DEA) published a document 
in the Federal Register on November 22, 2019, concerning a notice of 
application. As that document correctly indicated, the applicant, S&B 
Pharma, Inc., DBA Norac Pharma, 405 South Motor Avenue, Azusa, 
California 91702-3232 applied to be registered as a bulk manufacturer 
of a number of controlled substances, to include applying for 
authorization in order to synthetically manufacture using drug code 
7360 (marihuana). However, on the notice of application published, drug 
code 7360 was inadvertently identified and listed as Gamma 
Hydroxybutyric Acid instead of Marihuana.

SUPPLEMENTARY INFORMATION: 

Correction

    In the Federal Register of November 22, 2019, in FR Doc. 2019-25402 
(84 FR 64563), on page 64564, correct the listing of drug code 7360 to 
be identified as Marihuana, as is shown below.

------------------------------------------------------------------------
         Controlled substance           Drug code         Schedule
------------------------------------------------------------------------
Marihuana............................       7360   I
------------------------------------------------------------------------


    Dated: February 11, 2020.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-04829 Filed 3-9-20; 8:45 am]
 BILLING CODE 4410-09-P